Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Ranju Baral"'
Autor:
Joyce U. Nyiro, Bryan O. Nyawanda, Martin Mutunga, Nickson Murunga, D. James Nokes, Godfrey Bigogo, Nancy A. Otieno, Shirley Lidechi, Bilali Mazoya, Mark Jit, Cheryl Cohen, Jocelyn Moyes, Clint Pecenka, Ranju Baral, Clayton Onyango, Patrick K. Munywoki, Elisabeth Vodicka
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Respiratory syncytial virus (RSV) is one of the main causes of hospitalization for lower respiratory tract infection in children under five years of age globally. Maternal vaccines and monoclonal antibodies for RSV prevention amon
Externí odkaz:
https://doaj.org/article/687a84e006a1427eaad0c4cb6450d154
Autor:
Boshen Jiao, Isabelle Iversen, Ryoko Sato, Clint Pecenka, Sadaf Khan, Ranju Baral, Margaret E Kruk, Catherine Arsenault, Stéphane Verguet
Publikováno v:
PLoS Medicine, Vol 21, Iss 7, p e1004421 (2024)
BackgroundAntenatal care (ANC) is essential for ensuring the well-being of pregnant women and their fetuses. This study models the association between achieving adequate ANC and various health and health-seeking indicators across wealth quintiles in
Externí odkaz:
https://doaj.org/article/a84ca45fffa54d06a1b0cfcaf89154da
Autor:
Julia Dvorkin, Emiliano Sosa, Elizabeth Vodicka, Ranju Baral, Andrea Sancilio, Karina Dueñas, Andrea Rodriguez, Carlos Rojas-Roque, Patricia B. Carruitero, Fernando P. Polack, Clint Pecenka, Romina Libster, Mauricio T. Caballero
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Information is scarce regarding the economic burden of respiratory syncytial virus (RSV) disease in low-resource settings. This study aimed to estimate the cost per episode of hospital admissions due to RSV severe disease in Argen
Externí odkaz:
https://doaj.org/article/dc8fe1de29fe47cb9c215358b5bf93e5
Autor:
Ranju Baral, Clint Pecenka, Elisabeth Vodicka, Andrea Rodríguez, Julia Dvorkin, Emiliano M Sosa, Andrea Sancilio, Karina Dueñas, Carlos Rojas-Roque, Patricia B Carruitero, Fernando P Polack, Mauricio T Caballero
Publikováno v:
BMJ Public Health, Vol 2, Iss 1 (2024)
Introduction There is lack of available data on the economic burden of wheezing episodes after severe respiratory syncytial virus (RSV) infection. This study aimed to assess the cost incurred for wheezing episodes after a severe RSV infection in chil
Externí odkaz:
https://doaj.org/article/ae4a7e4bf3dc4feabf4d216c4eec3af7
The cost of typhoid illness in low- and middle-income countries, a scoping review of the literature.
Autor:
Frederic Debellut, Alena Friedrich, Ranju Baral, Clint Pecenka, Emmanuel Mugisha, Kathleen M Neuzil
Publikováno v:
PLoS ONE, Vol 19, Iss 6, p e0305692 (2024)
Typhoid fever is responsible for a substantial health burden in low- and middle-income countries (LMICs). New means of prevention became available with the prequalification of typhoid conjugate vaccines (TCV) by the World Health Organization (WHO) in
Externí odkaz:
https://doaj.org/article/149ae192873d400c9818befae85d48f2
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background Respiratory syncytial virus (RSV) is a leading cause of respiratory disease in young children. A number of mathematical models have been used to assess the cost-effectiveness of RSV prevention strategies, but these have not been d
Externí odkaz:
https://doaj.org/article/6c751b2e4b584d80b7a2624fb04ec0be
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract Background Approximately 97% of global deaths due to RSV occur in low- and middle-income countries (LMICs). Until recently, the only licensed preventive intervention has been a shortacting monoclonal antibody (mAb), palivizumab (PVZ) that is
Externí odkaz:
https://doaj.org/article/35ed6402930f4de8bf1f212dccacae9e
Autor:
Jean Bosco Ouédraogo, Alassane Dicko, Ranju Baral, Clint Pecenka, Halimatou Diawara, Fadima Yaya Bocoum, Ann Levin, Cynthia Lee, Fatoumata Koita, Rosemonde Guissou, Seydou Yabré, Seydou Traoré, Winthrop Morgan
Publikováno v:
BMJ Global Health, Vol 8, Iss 4 (2023)
Background The WHO recommends use of the RTS,S/AS01E (RTS,S) malaria vaccine for young children living in areas of moderate to high Plasmodium falciparum malaria transmission and suggests countries consider seasonal vaccination in areas with highly s
Externí odkaz:
https://doaj.org/article/a7f508df120c4efea52a2f7785f6063f
Autor:
Rachel S Laufer, Ranju Baral, Andrea G Buchwald, James D Campbell, Flanon Coulibaly, Fatoumata Diallo, Moussa Doumbia, Amanda J Driscoll, Alison P Galvani, Adama M Keita, Kathleen M Neuzil, Samba Sow, Clint Pecenka, Justin R Ortiz, Meagan C Fitzpatrick
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 5, p e0001432 (2023)
Respiratory syncytial virus (RSV) is the most common cause of early childhood lower respiratory tract infection (LRTI) in low- and middle-income countries (LMICs). Maternal vaccines, birth-dose extended half-life monoclonal antibodies (mAbs), and ped
Externí odkaz:
https://doaj.org/article/be68965fcf674c6e8e4e1bc521d36f8a
Autor:
Bryan O. Nyawanda, Victor A. Opere, Joyce U. Nyiro, Elisabeth Vodicka, Jessica A. Fleming, Ranju Baral, Sadaf Khan, Clint Pecenka, Jorim O. Ayugi, Raphael Atito, James Ougo, Godfrey Bigogo, Gideon O. Emukule, Nancy A. Otieno, Patrick K. Munywoki
Publikováno v:
Vaccines, Vol 11, Iss 6, p 1055 (2023)
Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infection (LRTI) among infants under 6 months of age. Yet, in Kenya, little is known about healthcare workers’ (HCWs) knowledge, attitudes, and perceptions around RSV dis
Externí odkaz:
https://doaj.org/article/e1362cc588fc4d4ca91bc8c1b1d17447